Climb Bio, Inc. (CLYM) Reports Q4 Loss of $0.13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: CLYM) | Delayed: 10.19 -0.35 (3.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.54 | 52 Week High | $ | |||
| Open | $10.47 | 52 Week Low | $ | |||
| Day High | $10.66 | P/E | N/A | |||
| Day Low | $10.05 | EPS | $ | |||
| Volume | 495,679 | |||||
